Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomas

BACKGROUND: Whereas 40 % to 70 % of papillary thyroid carcinomas (PTCs) are characterized by a BRAF mutation (BRAF(mut)), unified biomarkers for the genetically heterogeneous group of BRAF wild type (BRAF(wt)) PTCs are not established yet. Using state-of-the-art technology we compared RNA expression...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Genomics
Päätekijät: Schulten, Hans-Juergen, Alotibi, Reem, Al-Ahmadi, Alaa, Ata, Manar, Karim, Sajjad, Huwait, Etimad, Gari, Mamdooh, Al-Ghamdi, Khalid, Al-Mashat, Faisal, Al-Hamour, Osman Abdel, Al-Qahtani, Mohammad Hussain, Al-Maghrabi, Jaudah
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4315163/
https://ncbi.nlm.nih.gov/pubmed/25922907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2164-16-S1-S6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia